Implementation and Evaluation of a Post-Diagnostic Announcement Protocol at the CRMR RefeRet, Quinze-Vingts Hospital
Implementation and Evaluation of a Post-diagnostic Announcement Protocol at the CRMR RefeRet of the Quinze-Vingts National Ophthalmology Hospital
Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts
80 participants
Dec 1, 2025
INTERVENTIONAL
Conditions
Summary
This study explores whether adding early nurse-led and psychological support after the diagnosis of retinitis pigmentosa (RP) can improve patient experience and emotional well-being. RP is a rare, progressive eye disease often diagnosed after a long and difficult process, and receiving the diagnosis can be emotionally distressing. Eighty newly diagnosed adults will be randomly assigned to either usual care or an enhanced pathway that includes early follow-up with a nurse, structured emotional monitoring, and a psychologist visit at six months. The study aims to determine if this structured support improves patient satisfaction and reduces anxiety and depression compared with standard care.
Eligibility
Inclusion Criteria6
- Diagnosed with retinitis pigmentosa (RP) and followed at the Quinze-Vingts Rare Eye Disease Center, with diagnosis made after the project begins
- Aged 18 to 65 years
- Male or female
- French-speaking
- Have a phone number
- Reside in France
Exclusion Criteria5
- Pregnant women
- Participants enrolled in a therapeutic clinical trial within the past 12 months
- Individuals deprived of liberty by judicial or administrative decision
- Adults under legal protection or unable to provide informed consent
- Individuals with other medical conditions or taking treatments that could interfere with study evaluations
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Nurse-led and psychologist consultation
Standard ophthalmologist consultation with optional psychologist consultation
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07292987